LC
TECX

Lindbrook Capital’s Tectonic Therapeutic TECX Stock Holding History

Lindbrook Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8
Closed -$1K – 2028
2021
Q2 		$1K Buy
+8
New +$948 ﹤0.01% 1857
2020
Q4 		– Sell
-1
Closed – – 1896
2020
Q3 		$0 Sell
1
-4
-80% -$806 ﹤0.01% 1859
2020
Q2 		$1K Buy
5
+2
+67% +$412 ﹤0.01% 1653
2020
Q1 		$1K Buy
+3
New +$707 ﹤0.01% 1599

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Lindbrook Capital's TECX Position: Q3 2021 in Review

Lindbrook Capital sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 8 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in TECX in Q1 2020 and held it in 4 quarters. The position peaked at $1K in Q2 2021. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Lindbrook Capital reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Lindbrook Capital sold 8 Tectonic Therapeutic shares in Q3 2021, an estimated $1K.
  • Lindbrook Capital first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 4 quarters.
  • Lindbrook Capital's Tectonic Therapeutic position peaked at $1K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Lindbrook Capital's 13F filing for Q3 2021, filed 5 Nov 2021.